SEC Form 4 · accession 0001209191-16-154060
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Vasella
Director
Period of report
Dec 1, 2016
Accepted (ET)
Dec 8, 2016 · 11:13 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $13.27 | Dec 1, 2016 | A | 23,867 | A | Dec 1, 2016 | Nov 30, 2026 | Common Stock | 23,867 | 23,867 | D |
| Stock OptionF1 | $15.00 | Dec 1, 2016 | D | 125,000 | D | Nov 4, 2014 | Nov 3, 2019 | Common Stock | 125,000 | 0 | D |
| Stock OptionF1 | $15.00 | Dec 1, 2016 | A | 125,000 | A | Nov 4, 2014 | Nov 3, 2024 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1On 12/1/2016, regarding the 125,000 stock options previously granted to the Reporting Person on 11/4/2014, the Option Agreement was amended in order to extend the Expiration Date to the tenth anniversary of the date of grant and to confirm that following a Termination, the exercise period with respect to vested Options will remain in effect until the Expiration Date. Therefore the original option grant is deemed canceled and a new option grant is re-issued with the updated terms. The expiration date for the 125,000 options granted on 11/4/2014 was originally reported incorrectly on a Form 3 filed with the SEC on 4/14/2015. The accurate expiration date was 11/03/2019 at the time of the filing.